Research of Carney Complex has been linked to Neoplasms, Myxoma, Multiple Endocrine Neoplasia, Adenoma, Pituitary Diseases. The study of Carney Complex has been mentioned in research publications which can be found using our bioinformatics tool below. Researched pathways related to Carney Complex include Pigmentation, Pathogenesis, Cell Cycle, Secretion, Cell Proliferation. These pathways complement our catalog of research reagents for the study of Carney Complex including antibodies and ELISA kits against PRKAR1A, PROTEIN KINASE A, PKA, AIP, MEN1.
Carney Complex Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Carney Complex below!
For more information on how to use Laverne, please read the How to Guide.
We have 1792 products for the study of Carney Complex that can be applied to Chromatin Immunoprecipitation, Flow Cytometry, Western Blot, Immunocytochemistry/Immunofluorescence, Chromatin Immunoprecipitation (ChIP), Immunohistochemistry from our catalog of antibodies and ELISA kits.
Carney Complex is also known as carney complex, carney syndrome, carney complex, type 1, name syndrome, lamb syndrome, lamb - lentigines, atrial myxoma, mucocutaneous myoma, blue nevus syndrome, name - nevi, atrial myxoma, skin myxoma, ephelides syndrome, myxoma, spotty pigmentation, and endocrine overactivity, myxoma-spotty pigmentation-endocrine overactivity, carney myxoma-endocrine complex, carney complex, type ii, carney complex, type 2, melanocytic nevus, lentigo, myxoma, cnc1, car.
PRODUCT AVAILABILITY: Update Regarding the Evolving COVID-19 Situation
Bio-Techne appreciates the critical role that you and our products and services play in research efforts to further scientific innovation and discovery. We are continually assessing our manufacturing and supplier capabilities during the COVID-19 situation and are implementing precautionary measures to ensure uninterrupted supply of products and services. Currently, and as we abide by local shelter in place orders across the world, we are fully operational and do not anticipate any material supply disruptions across our Bio-Techne brands and product lines. As the situation evolves, our goal is to utilize preventive measures to reduce the threat that COVID-19 poses to our ability to meet the needs of our customers globally.